Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara M Tolaney

Showing results (41-50 of 372) with videos related to

Pageof 38
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2023
Reply to G.-F. Li et al, K. Altundag, and N. SG et alHope S Rugo, Aditya Bardia, Sara M Tolaney
Oncotargets and Therapy|July 16, 2019
Evidence to date: talazoparib in the treatment of breast cancerPedro Exman, Romualdo Barroso-Sousa, Sara M Tolaney
Cancer|October 7, 2018
Optimal treatment of early stage HER2-positive breast cancerSonia Pernas, Romualdo Barroso-Sousa, Sara M Tolaney
Future Oncology (London, England)|March 29, 2018
De-escalating treatment in the adjuvant setting in HER2-positive breast cancerRomualdo Barroso-Sousa, Pedro Exman, Sara M Tolaney
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|November 21, 2025
Erratum: Decoding Clinical Trials in Metastatic Breast Cancer: Practical Insights for Optimal Therapy SequencingChiara Corti, Hope S Rugo, Sara M Tolaney
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 14, 2025
Decoding Clinical Trials in Metastatic Breast Cancer: Practical Insights for Optimal Therapy SequencingChiara Corti, Hope S Rugo, Sara M Tolaney
JAMA Oncology|June 16, 2022
Aiming for the Cure in ERBB2-Positive Metastatic Breast Cancer-Should We Go "All In"?-ReplyPaolo Tarantino, Heather A Parsons, Sara M Tolaney
Breast Care (Basel, Switzerland)|August 6, 2016
Clinical Development of the CDK4/6 Inhibitors Ribociclib and Abemaciclib in Breast CancerRomualdo Barroso-Sousa, Geoffrey I Shapiro, Sara M Tolaney
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 8, 2022
Impact of RxPONDER and monarchE on the Surgical Management of the Axilla in Patients With Breast CancerElizabeth A Mittendorf, Tari A King, Sara M Tolaney
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 1, 2017
Optimal Management of Early and Advanced HER2 Breast CancerSara A Hurvitz, Karen A Gelmon, Sara M Tolaney
Pageof 38

Showing results (41-50 of 372) with videos related to

Sort By:
Pageof 38
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2023
Reply to G.-F. Li et al, K. Altundag, and N. SG et alHope S Rugo, Aditya Bardia, Sara M Tolaney
Oncotargets and Therapy|July 16, 2019
Evidence to date: talazoparib in the treatment of breast cancerPedro Exman, Romualdo Barroso-Sousa, Sara M Tolaney
Cancer|October 7, 2018
Optimal treatment of early stage HER2-positive breast cancerSonia Pernas, Romualdo Barroso-Sousa, Sara M Tolaney
Future Oncology (London, England)|March 29, 2018
De-escalating treatment in the adjuvant setting in HER2-positive breast cancerRomualdo Barroso-Sousa, Pedro Exman, Sara M Tolaney
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|November 21, 2025
Erratum: Decoding Clinical Trials in Metastatic Breast Cancer: Practical Insights for Optimal Therapy SequencingChiara Corti, Hope S Rugo, Sara M Tolaney
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 14, 2025
Decoding Clinical Trials in Metastatic Breast Cancer: Practical Insights for Optimal Therapy SequencingChiara Corti, Hope S Rugo, Sara M Tolaney
JAMA Oncology|June 16, 2022
Aiming for the Cure in ERBB2-Positive Metastatic Breast Cancer-Should We Go "All In"?-ReplyPaolo Tarantino, Heather A Parsons, Sara M Tolaney
Breast Care (Basel, Switzerland)|August 6, 2016
Clinical Development of the CDK4/6 Inhibitors Ribociclib and Abemaciclib in Breast CancerRomualdo Barroso-Sousa, Geoffrey I Shapiro, Sara M Tolaney
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 8, 2022
Impact of RxPONDER and monarchE on the Surgical Management of the Axilla in Patients With Breast CancerElizabeth A Mittendorf, Tari A King, Sara M Tolaney
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 1, 2017
Optimal Management of Early and Advanced HER2 Breast CancerSara A Hurvitz, Karen A Gelmon, Sara M Tolaney
Pageof 38